Alogliptin Placebo

DRUG3 trials

Sponsors

Takeda

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 3

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

CompletedNCT00328627

TakedaType 2 Diabetes Mellitus

Start: 2006-05-31End: 2008-03-31Updated: 2013-04-04

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes

CompletedNCT01023581

TakedaDiabetes Mellitus, Type 2

Start: 2009-11-30End: 2011-06-30Updated: 2013-03-26

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

CompletedNCT01890122

TakedaDiabetes Mellitus

Start: 2013-09-30End: 2015-10-31Updated: 2016-11-28

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01